Wockhardt gets GMP Compliance Certificate for manufacturing unit in Ankleshwar

23 Aug 2019

Wockhardt has received GMP Compliance Certificate from French National Agency for Medicines and Health Products Safety for its manufacturing Unit at Ankleshwar, Gujarat. The manufacturing facility complies with the principles of Good Manufacturing Practices for active substances.

This is reflected in the Eudra GMDP database. The said GMP Compliance Certificate is valid for a period of 3 years i.e. upto April 2, 2022. EudraGMDP is the name of the European Union database which inter-alia contains Good Manufacturing (GMP) Certificates.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Related Wockhardt Ltd. Links:

Wockhardt Share Price

307.50 -24.60 (-7.41%) Feb 28, 17:57
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 372.95
Lupin 639.70
Dr. Reddys Lab 2925.80
Piramal Enterprises 1307.35
Cadila Healthcare 260.05
View more..
Sensex vs Wockhardt
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463